Clinical trial
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in…
NCT00079274 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00079274 |
|---|---|
| Title | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer |
| Official title | A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Eastern Cooperative Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Colon, Stage III Colon Cancer |
| Intervention type | Biological, Drug |
| Interventions | irinotecan hydrochloride, oxaliplatin, leucovorin calcium, fluorouracil, cetuximab, Locally Directed Therapy |
| Enrollment | 3,397 |
| Start date | Feb 1, 2004 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Mar 10, 2004 |
| Last update posted | May 13, 2020 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: